Liver Cancer Diagnostic Market (By Screening Type: Laboratory Tests [Biomarkers {Oncofetal and Glycoprotein Antigens, Enzymes and Isoenzymes, Growth Factors and Receptors, Molecular Markers, Pathological Biomarkers}, Blood Tests], Imaging, Endoscopy, Biopsy, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global liver cancer diagnostics market worth is anticipated to around USD 15.2 billion by 2026, this market is foreseen to develop with 8.3% CAGR during the forecast time period. Rise in sickness frequency combined with developing demand for novel finding products are pushing the development of the market.

Market Dynamics

Rising illness frequency, developing mindfulness, and expanded utilization of advanced cancer screening products are some of the key variables impelling the market development. Hepatocellular Carcinoma (HCC) is the most widely recognized sort of essential liver cancer growth in grown-ups. Different hazard factors have been related with HCC, which incorporate hepatitis, obesity, exposure to dietary aflatoxin, alcohol-induced cirrhosis, and diabetes. It tends to be averted at a beginning period by different screening strategies, for example, lab tests, imaging, and endoscopy. This is likewise expanding the market development.

Market Insights

Expanded predominance of cancer growth, reception of new identification systems, and accessibility of effective disease medications are additionally driving the market. Moreover, strong government activities that assistance bring issues to light with respect to the illness and great repayment offices under the Affordable Care Act are boosting the market development. Precise identification of movement of cancer growth is basic for the choice of suitable treatment routine. At present, the accessible tests indicate false positive outcomes now and again. In this manner, confirmatory tests are required, which expands the money related burden on patients.
Tests utilizing specific biomarkers and tumor markers give relatively increasingly precise outcomes. This presents as an open door for industry members to create tumor-specific biomarkers and enhanced indicative methodology for liver carcinoma. Neglected requirement for medications giving total reductions and dependable reaction exists in the HCC space, which exhibits a strong opportunity to create leap forward first-in-class analytic strategies and treatments.

Market Segmentation

Market By Screening Type

  • Laboratory Tests
    • Biomarkers
      • Oncofetal and Glycoprotein Antigens
      • Enzymes and Isoenzymes
      • Growth Factors and Receptors
      • Molecular Markers
      • Pathological Biomarkers
    • Blood Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America drove the worldwide market in 2018 representing over 34.7% piece of the overall industry. The region is relied upon to keep up the main position all through the forecast period upheld by excellent healthcare coverage inclusion and innovative progressions. U.S. initiates the market in North America region. Presence of a substantial base of target populace, demand for consideration diagnostics, enhanced innovation, and snappy reception of novel therapeutics and indicative methodologies are the key variables in responsible for the region’s large share.

Asia Pacific is relied upon to display the most astounding development because of expanding occurrences of liver cancer growth and developing significance of bringing down the expense of disease medicines in creating nations, for example, India and China. Developing restorative the travel industry in these nations is likewise expected to support the demand for demonstrative methodology for liver carcinoma. Furthermore, expanded demands in research and advancement and ideal government approaches for human services gadgets makers are foreseen to drive the locale's development further.

Market Participants

Few of the main player present in the global liver cancer diagnostic market are Thermo Fisher Scientific, Illumina, Inc.; Siemens Healthcare GmbH; Qiagen; and F. Hoffmann-La Roche Ltd.


Related Reports

Recombinant Plasma Protein Therapeutics Market (By Drug Class: Human C1 Esterase Inhibitor, Recombinant Coagulation Factors; By Cell Line: Chinese Hamster Ovary (CHO) Cell Line, Human Embryonic Kidney (HEK) Cell Line, Baby Hamster Kidney (BHK) Cell Line, Others; By Indication: Hemophilia B, Hemophilia A, Von Willebrand Disease) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction The report provides analysis of global Recombinant Plasma Protein Therapeutics market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Recombinant Plasma Protein Therapeutics market is expected to grow at noteworthy CAGR around 8.3 % throughout

Membrane Microfiltration Market (By Material Type: Direct Flow Membranes, Cross Flow Membranes; By Application: Biopharmaceutical Processing, Dairy & Food Processing, Water Treatment Application, Chemical Application, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction The report provides analysis of global Membrane Microfiltration market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Membrane Microfiltration market is expected to grow at noteworthy CAGR around 7.1 % throughout the forecast period and reach

Lithotripsy Device Market (By Product: Extracorporeal Lithotripsy, Intracorporeal Lithotripsy; By Application: Kidney Stones Biliary Duct Stones, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction Lithotripsy is a process used to break stones of the kidney and other organs such as the gall bladder, liver and urethra through a ultrasound shock wave. Kidney stones occur when substances like urine crystallize in stones or solid mass forming the kidneys and thus prevent the urine from passing through your body. This can lead to bleeding, severe urinary pain, infecti

Bioanalytical Testing Services Market (By Molecule Type: Large Molecule [Immunoassays, LC-MS Studies,Others], Small Molecule; By Test Type: ADME [In-Vitro, In-Vivo], PD, PK, Bioequivalence, Bioavailability, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction A series of methods used to determine the quantity and the metabolites of active drugs in the human body is provided by bioanalytical testing services. It is vital to the development of medicines and to the success of the medicine. During the forecast period, the need for quick action medicines to treat chronic diseases is predicted to boost market demand. Continuous progress in research and d

Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction The report provides analysis of global Cardiovascular & Soft Tissue Repair Patches market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Cardiovascular & Soft Tissue Repair Patches market is expected to grow at noteworthy CAGR around 8 % throughout the forecas

Virus Filtration Market (By Product Type: Virus Filters & Filtration Systems, Kits & Reagents, Services; By Application: Biological [Blood & Blood Products, Tissue & Tissue Products, Vaccines & Therapeutics, Cellular & Gene Therapy Products, Stem Cell Products], Medical Devices, Water Purification, Air Purification; By End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organization, Medical Devices Companies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Virus filtration are mainly used to maintain a pathogen such as bacteria, virus, and microbe’s free environment. Presence of pathogens in labs, and biotechnology industries lead to the contamination of water, air, and biotheraputics. Virus filtration maintains the environment and products safety. It also ensures that the products manufactured are of high grade. The market research study on “Virus Filtration Market

Cart Summary